High-resolution 3D visualization of nanomedicine distribution in tumors

• Published in: Theranostics Vol. 10; no. 2; pp. 880 - 897
• Main Authors: Moss, Jennifer I, Barjat, Hervé, Emmas, Sally-Ann, Strittmatter, Nicole, Maynard, Juliana, Goodwin, Richard J A, Storm, Gert, Lammers, Twan, Puri, Sanyogitta, Ashford, Marianne B, Barry, Simon T
• Format: Journal Article
• Language: English
• Published: Australia Ivyspring International Publisher Pty Ltd 2020; Ivyspring International Publisher
• Subjects: Animals; Biodistribution; Cancer therapies; Cell Line, Tumor; Contrast Media - chemistry; Contrast Media - pharmacology; Histology; Humans; Imaging, Three-Dimensional - methods; Liposomes - chemistry; Localization; Male; Mice; Mice, SCID; Nanomedicine - methods; Nanoparticles - administration & dosage; Nanoparticles - chemistry; Neoplasms - diagnostic imaging; Neoplasms - drug therapy; Neoplasms - pathology; Patients; Permeability; Pharmacokinetics; Research Paper; Retention; Tumor Microenvironment; Tumors; X-Ray Microtomography - methods; Xenograft Model Antitumor Assays; United Kingdom > UK; vasculature; nanomedicine; tumor microenvironment; µCT imaging; distribution; EPR
• ISSN: 1838-7640; 1838-7640
• DOI: 10.7150/thno.37178

To improve the clinical translation of anti-cancer nanomedicines, it is necessary to begin building specific insights into the broad concept of the Enhanced Permeability and Retention (EPR) effect, using detailed investigations of the accumulation, distribution and retention of nanomedicines in solid tumors. Nanomedicine accumulation in preclinical tumors has been extensively studied; however, treatment efficacy will be heavily influenced by both the quantity of drug-loaded nanomedicines reaching the tumor as well as their spatial distribution throughout the tumor. It remains a challenge to image the heterogeneity of nanomedicine distribution in 3 dimensions within solid tumors with a high degree of spatial resolution using standard imaging approaches. To achieve this, an ex vivo micro computed tomography (µCT) imaging approach was developed to visualize the intratumoral distribution of contrast agent-loaded PEGylated liposomes. Using this semi-quantitative method, whole 3-dimensional (3D) tumor liposome distribution was determined with 17 µm resolution in a phenotypically diverse panel of four preclinical xenograft and patient-derived explant (PDX) tumor models. High-resolution ex vivo μCT imaging revealed striking differences in liposome distribution within tumors in four models with different vascular patterns and densities, stromal contents, and microenvironment morphologies. Following intravenous dosing, the model with the highest density of pericyte-supported vessels showed the greatest liposome accumulation, while the model with vessels present in regions of high α-smooth muscle actin (αSMA) content presented with a large proportion of the liposomes at depths beyond the tumor periphery. The two models with an unsupported vascular network demonstrated a more restricted pattern of liposome distribution. Taken together, vessel distribution and support (the latter indicative of functionality) appear to be key factors determining the accumulation and distribution pattern of liposomes in tumors. Our findings demonstrate that high-resolution 3D visualization of nanomedicine distribution is a useful tool for preclinical nanomedicine research, providing valuable insights into the influence of the tumor vasculature and microenvironment on nanomedicine localization.